PRIM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.724800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.402200E-01
Normal-vs-Stage2
8.623400E-01
Normal-vs-Stage3
1.463790E-01
Normal-vs-Stage4
7.415600E-01
Stage1-vs-Stage2
2.177000E-01
Stage1-vs-Stage3
6.009400E-01
Stage1-vs-Stage4
1.589220E-01
Stage2-vs-Stage3
1.197560E-01
Stage2-vs-Stage4
5.617800E-01
Stage3-vs-Stage4
5.279600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.092000E-01
Normal-vs-AfricanAmerican
4.780600E-01
Normal-vs-Asian
3.209600E-01
Caucasian-vs-AfricanAmerican
7.076200E-01
Caucasian-vs-Asian
2.362200E-01
AfricanAmerican-vs-Asian
5.377200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.692400E-01
Normal-vs-Female
6.446200E-01
Male-vs-Female
3.553800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.695600E-01
Normal-vs-Age(41-60Yrs)
9.065600E-01
Normal-vs-Age(61-80Yrs)
6.431000E-01
Normal-vs-Age(81-100Yrs)
7.763800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.962600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.797400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.564800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.183400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.808400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.707200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.968600E-01
Normal-vs-Daily Drinker
4.465400E-01
Normal-vs-Weekly Drinker
7.556000E-01
Normal-vs-Occasional Drinker
9.274200E-01
Normal-vs-Social Drinker
8.584200E-01
Non Drinker-vs-Daily Drinker
3.821400E-01
Non Drinker-vs-Weekly Drinker
8.945400E-01
Non Drinker-vs-Occasional Drinker
3.350600E-01
Non Drinker-vs-Social Drinker
7.341600E-01
Daily Drinker-vs-Weekly Drinker
3.994600E-01
Daily Drinker-vs-Occasional Drinker
1.020600E-01
Daily Drinker-vs-Social Drinker
3.129000E-01
Weekly Drinker-vs-Occasional Drinker
4.851600E-01
Weekly Drinker-vs-Social Drinker
8.590200E-01
Occasional Drinker-vs-Social Drinker
6.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.063200E-01
Normal-vs-Grade 2
9.619000E-01
Normal-vs-Grade 3
9.545200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.700900E-03
Grade 1-vs-Grade 3
1.183540E-03
Grade 1-vs-Grade 4
8.063200E-01
Grade 2-vs-Grade 3
1.424600E-01
Grade 2-vs-Grade 4
9.619000E-01
Grade 3-vs-Grade 4
9.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.582000E-01
Normal-vs-NonDiabetic
6.977400E-01
Diabetic-vs-NonDiabetic
7.938600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.887400E-01
Normal-vs-NoPancreatitis
7.391400E-01
Pancreatitis-vs-NoPancreatitis
4.189600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.518600E-01
Normal-vs-N1
8.661000E-01
N0-vs-N1
4.180600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.645200E-01
Normal-vs-TP53-NonMutant
6.392800E-01
TP53-Mutant-vs-TP53-NonMutant
5.633800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
